A bipartisan group of lawmakers representing Sanford is sponsoring the legislation, which went to a public hearing Monday. If ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...

The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials, all in ready-to-fill formats. Container filling can be performed via peristaltic pump or ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...

Company to Roll Out Availability of IMKELDI (imatinib) for Patients with Certain Forms of Leukemia and Other Cancers Shorla Oncology ('Shorla'), a U.S.-Ireland specialty pharmaceutical company, ...

NAFDAC further warned that this syringe is no longer registered and its continued use poses a serious risk of dosing errors, which ...

Otulfi will be available in the U.S. in the following presentations: a 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL (5 mg/mL) single dose vial for IV ...

Tidal volume and minute volume increased progressively throughout the first postoperative hour while arterial carbon dioxide tension varied less than 2 mm of mercury. Twenty minutes after the ...

Deaths of 2 Nunavut care home residents ... In one example, it found nurses were reusing single-use syringes. In another, a staff member gave the wrong medication to a child.